- Home
- PHGE vs YGMZ Comparison
PHGE vs YGMZ Comparison
Compare PHGE & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- YGMZ
- Stock Information
- Founded
- PHGE 2015
- YGMZ 2002
- Country
- PHGE Israel
- YGMZ China
- Employees
- PHGE N/A
- YGMZ N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- YGMZ Transportation Services
- Sector
- PHGE Health Care
- YGMZ Consumer Discretionary
- Exchange
- PHGE Nasdaq
- YGMZ Nasdaq
- Market Cap
- PHGE 13.0M
- YGMZ 10.7M
- IPO Year
- PHGE N/A
- YGMZ 2020
- Fundamental
- Price
- PHGE $0.31
- YGMZ $1.26
- Analyst Decision
- PHGE Strong Buy
- YGMZ
- Analyst Count
- PHGE 1
- YGMZ 0
- Target Price
- PHGE $15.00
- YGMZ N/A
- AVG Volume (30 Days)
- PHGE 1.7M
- YGMZ 2.5M
- Earning Date
- PHGE 11-12-2025
- YGMZ 01-01-0001
- Dividend Yield
- PHGE N/A
- YGMZ N/A
- EPS Growth
- PHGE N/A
- YGMZ N/A
- EPS
- PHGE N/A
- YGMZ N/A
- Revenue
- PHGE N/A
- YGMZ $40,429,750.00
- Revenue This Year
- PHGE N/A
- YGMZ N/A
- Revenue Next Year
- PHGE N/A
- YGMZ N/A
- P/E Ratio
- PHGE N/A
- YGMZ N/A
- Revenue Growth
- PHGE N/A
- YGMZ N/A
- 52 Week Low
- PHGE $0.31
- YGMZ $1.13
- 52 Week High
- PHGE $1.16
- YGMZ $24.64
- Technical
- Relative Strength Index (RSI)
- PHGE 27.31
- YGMZ 68.21
- Support Level
- PHGE $0.35
- YGMZ $1.13
- Resistance Level
- PHGE $0.42
- YGMZ $1.71
- Average True Range (ATR)
- PHGE 0.04
- YGMZ 0.09
- MACD
- PHGE -0.01
- YGMZ 0.16
- Stochastic Oscillator
- PHGE 2.81
- YGMZ 69.21
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About YGMZ MingZhu Logistics Holdings Limited
MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. The segments of the company are the trucking business, car owner services business, and liquor distribution business.